289 related articles for article (PubMed ID: 21075512)
1. Genomic instability and cancer: lessons learned from human papillomaviruses.
Korzeniewski N; Spardy N; Duensing A; Duensing S
Cancer Lett; 2011 Jun; 305(2):113-22. PubMed ID: 21075512
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms of genomic instability in human cancer: insights from studies with human papillomavirus oncoproteins.
Duensing S; Münger K
Int J Cancer; 2004 Mar; 109(2):157-62. PubMed ID: 14750163
[TBL] [Abstract][Full Text] [Related]
3. Human Papillomavirus 16 Oncoprotein Expression Is Controlled by the Cellular Splicing Factor SRSF2 (SC35).
McFarlane M; MacDonald AI; Stevenson A; Graham SV
J Virol; 2015 May; 89(10):5276-87. PubMed ID: 25717103
[TBL] [Abstract][Full Text] [Related]
4. The human papillomavirus type 16 E6 and E7 oncoproteins independently induce numerical and structural chromosome instability.
Duensing S; Münger K
Cancer Res; 2002 Dec; 62(23):7075-82. PubMed ID: 12460929
[TBL] [Abstract][Full Text] [Related]
5. Centrosomes, genomic instability, and cervical carcinogenesis.
Duensing S; Münger K
Crit Rev Eukaryot Gene Expr; 2003; 13(1):9-23. PubMed ID: 12839094
[TBL] [Abstract][Full Text] [Related]
6. The human papillomavirus type 16 E6 and E7 oncoproteins cooperate to induce mitotic defects and genomic instability by uncoupling centrosome duplication from the cell division cycle.
Duensing S; Lee LY; Duensing A; Basile J; Piboonniyom S; Gonzalez S; Crum CP; Munger K
Proc Natl Acad Sci U S A; 2000 Aug; 97(18):10002-7. PubMed ID: 10944189
[TBL] [Abstract][Full Text] [Related]
7. Centrosome abnormalities and genomic instability induced by human papillomavirus oncoproteins.
Duensing S; Münger K
Prog Cell Cycle Res; 2003; 5():383-91. PubMed ID: 14593733
[TBL] [Abstract][Full Text] [Related]
8. Human papillomaviruses and centrosome duplication errors: modeling the origins of genomic instability.
Duensing S; Münger K
Oncogene; 2002 Sep; 21(40):6241-8. PubMed ID: 12214255
[TBL] [Abstract][Full Text] [Related]
9. Genomic Signatures in HPV-Associated Tumors.
Hussain SS; Lundine D; Leeman JE; Higginson DS
Viruses; 2021 Oct; 13(10):. PubMed ID: 34696429
[TBL] [Abstract][Full Text] [Related]
10. Human papillomavirus 16 E7 oncoprotein attenuates DNA damage checkpoint control by increasing the proteolytic turnover of claspin.
Spardy N; Covella K; Cha E; Hoskins EE; Wells SI; Duensing A; Duensing S
Cancer Res; 2009 Sep; 69(17):7022-9. PubMed ID: 19706760
[TBL] [Abstract][Full Text] [Related]
11. In vitro and in vivo growth inhibition of human cervical cancer cells via human papillomavirus E6/E7 mRNAs' cleavage by CRISPR/Cas13a system.
Chen Y; Jiang H; Wang T; He D; Tian R; Cui Z; Tian X; Gao Q; Ma X; Yang J; Wu J; Tan S; Xu H; Tang X; Wang Y; Yu Z; Han H; Das BC; Severinov K; Hitzeroth II; Debata PR; Xu W; Fan W; Jin Z; Cao C; Yu M; Xie W; Huang Z; Hu Z; You Z
Antiviral Res; 2020 Jun; 178():104794. PubMed ID: 32298665
[TBL] [Abstract][Full Text] [Related]
12. HPV-16 E6/E7 promotes cell migration and invasion in cervical cancer via regulating cadherin switch in vitro and in vivo.
Hu D; Zhou J; Wang F; Shi H; Li Y; Li B
Arch Gynecol Obstet; 2015 Dec; 292(6):1345-54. PubMed ID: 26093522
[TBL] [Abstract][Full Text] [Related]
13. TLR9 expression in uterine cervical lesions of Uyghur women correlate with cervical cancer progression and selective silencing of human papillomavirus 16 E6 and E7 oncoproteins in vitro.
Hao Y; Yuan JL; Abudula A; Hasimu A; Kadeer N; Guo X
Asian Pac J Cancer Prev; 2014; 15(14):5867-72. PubMed ID: 25081715
[TBL] [Abstract][Full Text] [Related]
14. TALEN-mediated targeting of HPV oncogenes ameliorates HPV-related cervical malignancy.
Hu Z; Ding W; Zhu D; Yu L; Jiang X; Wang X; Zhang C; Wang L; Ji T; Liu D; He D; Xia X; Zhu T; Wei J; Wu P; Wang C; Xi L; Gao Q; Chen G; Liu R; Li K; Li S; Wang S; Zhou J; Ma D; Wang H
J Clin Invest; 2015 Jan; 125(1):425-36. PubMed ID: 25500889
[TBL] [Abstract][Full Text] [Related]
15. [Molecular basis of cervical carcinogenesis by high-risk human papillomaviruses].
Yugawa T; Kiyono T
Uirusu; 2008 Dec; 58(2):141-54. PubMed ID: 19374192
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of cervical cancer cell growth by human papillomavirus virus-like particles packaged with human papillomavirus oncoprotein short hairpin RNAs.
Bousarghin L; Touze A; Gaud G; Iochmann S; Alvarez E; Reverdiau P; Gaitan J; Jourdan ML; Sizaret PY; Coursaget PL
Mol Cancer Ther; 2009 Feb; 8(2):357-65. PubMed ID: 19174559
[TBL] [Abstract][Full Text] [Related]
17. E6 and E7 oncoproteins induce distinct patterns of chromosomal aneuploidy in skin tumors from transgenic mice.
Schaeffer AJ; Nguyen M; Liem A; Lee D; Montagna C; Lambert PF; Ried T; Difilippantonio MJ
Cancer Res; 2004 Jan; 64(2):538-46. PubMed ID: 14744767
[TBL] [Abstract][Full Text] [Related]
18. Human Papillomavirus E6/E7 and Long Noncoding RNA TMPOP2 Mutually Upregulated Gene Expression in Cervical Cancer Cells.
He H; Liu X; Liu Y; Zhang M; Lai Y; Hao Y; Wang Q; Shi D; Wang N; Luo XG; Ma W; Zhang TC
J Virol; 2019 Apr; 93(8):. PubMed ID: 30728257
[TBL] [Abstract][Full Text] [Related]
19. Piwil2 is reactivated by HPV oncoproteins and initiates cell reprogramming via epigenetic regulation during cervical cancer tumorigenesis.
Feng D; Yan K; Zhou Y; Liang H; Liang J; Zhao W; Dong Z; Ling B
Oncotarget; 2016 Oct; 7(40):64575-64588. PubMed ID: 27602489
[TBL] [Abstract][Full Text] [Related]
20. HPV16 oncogenes E6 or/and E7 may influence the methylation status of RASSFIA gene promoter region in cervical cancer cell line HT-3.
Yin F; Wang N; Wang S; Yu F; Sun X; Yu X; Luo B; Zhao C; Wang Y
Oncol Rep; 2017 Apr; 37(4):2324-2334. PubMed ID: 28260046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
